ES2053837T3 - Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico. - Google Patents
Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico.Info
- Publication number
- ES2053837T3 ES2053837T3 ES89104619T ES89104619T ES2053837T3 ES 2053837 T3 ES2053837 T3 ES 2053837T3 ES 89104619 T ES89104619 T ES 89104619T ES 89104619 T ES89104619 T ES 89104619T ES 2053837 T3 ES2053837 T3 ES 2053837T3
- Authority
- ES
- Spain
- Prior art keywords
- pirrolidinyltio
- azabiciclo
- carboxilico
- eno
- hept
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
UN COMPUESTO DE LA FORMULA (I) EN LA QUE R EXP1 ES CARBOXI O CARBOXI PROTEGIDO, R (AL CUADRADO) ES HIDROXI (INFERIOR) ALQUILO O HIDROXI (INFERIOR) ALQUILO PROTEGIDO, R EXP3 ES HIDROGENO O ALQUILO INFERIOR, R EXP4 ES UN GRUPO HETEROCICLICO ALIFATICO QUE PUEDE SER SUSTITUIDO POR SUSTITUYENTE (S) CONVENIENTE, R EXP5 ES HIDROGENO, GRUPO ALQUILO INFERIOR O IMINO PROTECTOR Y A ES ALQUILENO INFERIOR, O SALES DE ESTO FARMACEUTICAMENTE ACEPTABLES, PROCESOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN COMO INGREDIENTE ACTIVO EN MEZCLA CON UN SOPORTE O EXCIPIENTE ACEPTABLE FARMACEUTICAMENTE.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888806428A GB8806428D0 (en) | 1988-03-18 | 1988-03-18 | 3-pyrrolidinylthio-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds |
GB888812159A GB8812159D0 (en) | 1988-05-23 | 1988-05-23 | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds |
GB888821760A GB8821760D0 (en) | 1988-09-16 | 1988-09-16 | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053837T3 true ES2053837T3 (es) | 1994-08-01 |
Family
ID=27263828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89104619T Expired - Lifetime ES2053837T3 (es) | 1988-03-18 | 1989-03-15 | Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4925838A (es) |
EP (1) | EP0333175B1 (es) |
JP (1) | JP2754679B2 (es) |
KR (1) | KR890014541A (es) |
AT (1) | ATE107306T1 (es) |
DE (1) | DE68916071T2 (es) |
ES (1) | ES2053837T3 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202437A (en) * | 1988-03-18 | 1993-04-13 | Fujisawa Pharmaceutical Company, Ltd. | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid compounds |
AU631671B2 (en) * | 1989-08-04 | 1992-12-03 | Banyu Pharmaceutical Co., Ltd. | 2-(2-vinylpyrrolidinylthio)carbapenem derivatives |
GB8923844D0 (en) * | 1989-10-23 | 1989-12-13 | Fujisawa Pharmaceutical Co | Carbapenem compounds |
DE69013131T2 (de) * | 1989-12-29 | 1995-05-24 | Banyu Pharma Co Ltd | 2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate. |
US5227376A (en) * | 1990-02-14 | 1993-07-13 | Sumitomo Pharmaceuticals Co., Ltd. | β-lactam compounds and their production |
CA2036941A1 (en) * | 1990-02-23 | 1991-08-24 | Isao Kawamoto | Carbapenem derivatives having antibiotic activity, their preparation and their use |
US5373002A (en) * | 1990-03-27 | 1994-12-13 | Banyu Pharmaceutical Co., Ltd. | 2-(substituted pyrrolidinylthio) carbapenem derivatives |
US5374720A (en) * | 1990-03-27 | 1994-12-20 | Banyu Pharmaceutical Co., Ltd. | 2-(substituted pyrrolidinylthio)carbapenem derivatives |
JPH0764846B2 (ja) * | 1990-03-27 | 1995-07-12 | 萬有製薬株式会社 | 2−(置換ピロリジニルチオ)カルバペネム誘導体 |
TW198034B (es) * | 1990-03-27 | 1993-01-11 | Manyu Seiyaku Kk | |
US5712267A (en) * | 1991-06-04 | 1998-01-27 | Sankyo Company,. Limited | Carbapenem derivatives, their preparation and their use as antibiotics |
WO1993006102A1 (en) * | 1991-09-27 | 1993-04-01 | Banyu Pharmaceutical Co., Ltd. | 2-(substituted pyrrolidinylthio) carbapenem derivative |
CA2117899A1 (en) * | 1992-04-13 | 1993-10-28 | Masayoshi Murata | Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents |
CA2099811A1 (en) * | 1992-07-21 | 1994-01-22 | Frederic H. Jung | Antibiotic compounds |
GB9320816D0 (en) * | 1993-10-08 | 1993-12-01 | Fujisawa Pharmaceutical Co | Novel compounds |
AU680736B2 (en) * | 1994-02-25 | 1997-08-07 | Banyu Pharmaceutical Co., Ltd. | Carbapenem derivative |
JP3848693B2 (ja) * | 1994-07-06 | 2006-11-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 新規カルバペネム誘導体 |
KR100345468B1 (ko) * | 2000-07-10 | 2002-07-26 | 한국과학기술연구원 | 신규 1-베타메틸카바페넴 유도체 및 그의 제조방법 |
KR100613196B1 (ko) | 2000-07-19 | 2006-08-18 | 에프. 호프만-라 로슈 아게 | 메탈로프로테아제 억제제로서의 피롤리딘 유도체 |
US7632828B2 (en) | 2004-06-10 | 2009-12-15 | Fob Synthesis, Inc. | Gram-positive carbapenem antibacterials and processes for their preparation |
WO2006045096A2 (en) | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
AU2006275514B2 (en) | 2005-07-29 | 2012-04-05 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
US8053440B2 (en) | 2007-02-01 | 2011-11-08 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular diseases |
JP5406181B2 (ja) * | 2007-06-28 | 2014-02-05 | ケービーピー・バイオサイエンシズ・カンパニー・リミテッド | 新規カルバペネム誘導体 |
CA2711103C (en) | 2008-06-26 | 2016-08-09 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
EP2382194B1 (en) | 2009-01-08 | 2014-03-12 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
JP5795304B2 (ja) | 2009-03-18 | 2015-10-14 | レスバーロジックス コーポレイション | 新規抗炎症剤 |
KR101892987B1 (ko) | 2009-04-22 | 2018-08-30 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
CA2802529C (en) | 2010-06-18 | 2019-10-29 | Woo-Baeg Choi | Carbapenem antibacterials with gram-negative activity |
DK2773354T3 (da) | 2011-11-01 | 2019-08-05 | Resverlogix Corp | Oralformuleringer med øjeblikkelig frigivelse for substituerede quinazolinoner |
WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
AU2013365926B9 (en) | 2012-12-21 | 2019-01-17 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
KR102662814B1 (ko) | 2015-03-13 | 2024-05-03 | 리스버로직스 코퍼레이션 | 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552873A (en) * | 1981-08-19 | 1985-11-12 | Sankyo Company Limited | Carbapenem compounds, and compositions containing them |
JPS5916892A (ja) * | 1982-07-19 | 1984-01-28 | Sankyo Co Ltd | カルバペネム−3−カルボン酸誘導体およびその製法 |
KR900006449B1 (ko) * | 1982-08-24 | 1990-08-31 | 상꾜 가부시끼가이샤 | 아제티디논 화합물의 제조방법 |
CA1283906C (en) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
JPS60202886A (ja) * | 1984-03-27 | 1985-10-14 | Sankyo Co Ltd | 1―置換カルバペネム―3―カルボン酸誘導体 |
EP0182213B1 (en) * | 1984-11-08 | 1990-09-26 | Sumitomo Pharmaceuticals Company, Limited | Carbapenem compounds and production thereof |
EP0243686B1 (en) * | 1986-03-27 | 1992-07-15 | Sumitomo Pharmaceuticals Company, Limited | Beta-lactam compounds, and their production |
ES2053508T3 (es) * | 1986-11-24 | 1994-08-01 | Fujisawa Pharmaceutical Co | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. |
KR880006244A (ko) * | 1986-11-24 | 1988-07-22 | 후지사와 도모 기찌 로 | 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 |
-
1989
- 1989-03-14 US US07/323,404 patent/US4925838A/en not_active Expired - Fee Related
- 1989-03-15 DE DE68916071T patent/DE68916071T2/de not_active Expired - Lifetime
- 1989-03-15 AT AT89104619T patent/ATE107306T1/de not_active IP Right Cessation
- 1989-03-15 ES ES89104619T patent/ES2053837T3/es not_active Expired - Lifetime
- 1989-03-15 EP EP89104619A patent/EP0333175B1/en not_active Expired - Lifetime
- 1989-03-16 JP JP1064888A patent/JP2754679B2/ja not_active Expired - Lifetime
- 1989-03-17 KR KR1019890003304A patent/KR890014541A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE68916071D1 (de) | 1994-07-21 |
JPH021491A (ja) | 1990-01-05 |
KR890014541A (ko) | 1989-10-24 |
EP0333175B1 (en) | 1994-06-15 |
EP0333175A1 (en) | 1989-09-20 |
DE68916071T2 (de) | 1994-10-20 |
US4925838A (en) | 1990-05-15 |
ATE107306T1 (de) | 1994-07-15 |
JP2754679B2 (ja) | 1998-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053837T3 (es) | Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico. | |
AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
ES2100302T3 (es) | Procedimiento para la fabricacion de composiciones de poliuretano cationico y sales de amonio cuaternario. | |
ES8303293A1 (es) | "procedimiento de preparar derivados carboxamidicos". | |
NO305477B1 (no) | Nye 3,3-difenylpropylaminer, farmas°ytiske preparater inneholdende slike forbindelser, og deres anvendelse | |
ES2059383T3 (es) | Compuestos de diamina. | |
NO951934L (no) | Fremgangsmåte for fremstilling av substituerte amidinoforbindelser, samt behandlingsmetoder | |
ES2053508T3 (es) | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. | |
NO953447L (no) | Nye 4-aminopyridiner, fremgangsmåte for deres fremstilling samt legemidler inneholdende disse | |
ES2053509T3 (es) | Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico y procedimientos para su preparacion. | |
ES8402559A1 (es) | Un procedimiento para preparar nuevos compuestos peptidicos. | |
ES2156933T3 (es) | Derivados triciclicos de benzazepina y benzotiazepina. | |
EP0281925A3 (en) | Method for protecting plants and plant matter from stress | |
ATE84045T1 (de) | Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen. | |
NO302072B1 (no) | Azabicyklo-arylacetylen- og -arylenyn-oksimer som cholinerge midler og preparater inneholdende slike | |
DK0553016T3 (da) | Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem | |
CO4180513A1 (es) | Derivados de acido isoftalico utiles para el tratamiento del sida | |
NO852514L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater. | |
AR027578A1 (es) | Derivados de indano | |
ES2053652T3 (es) | N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos. | |
ES2118094T3 (es) | Derivados del acido carbamico y procedimiento para su preparacion. | |
CA2118425A1 (en) | Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof | |
ATE43140T1 (de) | Derivate von enzym-hemmender griseolsaeure und deren verwendung. | |
DK645589D0 (da) | Arolyxopropanolaminotetraliner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem | |
JPS5646850A (en) | Method for reductive elimination of protecting group |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 333175 Country of ref document: ES |